Comparison between Hemant Surgical Industries IPO and Infollion Research IPO.
Hemant Surgical Industries IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Infollion Research IPO is a SME Bookbuilding proposed to list at NSE SME.
| Hemant Surgical Industries IPO | Infollion Research IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Hem Securities Ltd. | Holani Consultants Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Hem Finlease Pvt.Ltd. | Holani Consultants Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Hemant Surgical Industries IPO is up to ₹23.54 Cr whereas the issue size of the Infollion Research IPO is up to ₹20.36 Cr. The final issue price of Hemant Surgical Industries IPO is ₹90.00 per share and of Infollion Research IPO is ₹82.00 per share.
| Hemant Surgical Industries IPO | Infollion Research IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹85.00 per share | ₹80.00 per share |
| Issue Price (Upper) | ₹90.00 per share | ₹82.00 per share |
| Issue Price (Final) | ₹90.00 per share | ₹82.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 26,16,000 shares | 20,91,200 shares |
| Fresh Issue Size (Amount) | up to ₹23.54 Cr | up to ₹17.15 Cr |
| OFS Issue Size | 0 shares | 3,92,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹3.21 Cr |
| Issue Size Total | 26,16,000 shares | 24,83,200 shares |
| Issue Size Total (Amount) | up to ₹23.54 Cr | up to ₹20.36 Cr |
Hemant Surgical Industries IPO opens on May 24, 2023, while Infollion Research IPO opens on May 29, 2023. The closing date of Hemant Surgical Industries IPO and Infollion Research IPO is May 26, 2023, and May 31, 2023, respectively.
| Hemant Surgical Industries IPO | Infollion Research IPO | |
|---|---|---|
| Anchor Bid Date | May 23, 2023 | May 26, 2023 |
| Issue Open | May 24, 2023 | May 29, 2023 |
| Issue Close | May 26, 2023 | May 31, 2023 |
| Basis Of Allotment (Tentative) | May 31, 2023 | Jun 05, 2023 |
| Initiation of Refunds (Tentative) | Jun 01, 2023 | Jun 06, 2023 |
| Credit of Share (Tentative) | Jun 02, 2023 | Jun 07, 2023 |
| Listing date (Tentative) | Jun 05, 2023 | Jun 08, 2023 |
| Anchor Lockin End date 1 | Jun 30, 2023 | Jul 05, 2023 |
| Anchor Lockin End date 2 | Aug 29, 2023 | Sep 03, 2023 |
Hemant Surgical Industries IPO P/E ratio is 12.28, as compared to Infollion Research IPO P/E ratio of 14.24.
| Hemant Surgical Industries IPO | Infollion Research IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00 | 67.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.28 | 14.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹93.96 Cr. | ₹79.47 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 32.42 | 42.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.30 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 32.42 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Hemant Surgical Industries IPO Retail Individual Investors (RII) are offered 9,16,800 shares while in Infollion Research IPO retail investors are offered 9,16,800 shares. Qualified Institutional Buyers (QIB) are offered 5,23,200 shares in Hemant Surgical Industries IPO and 4,83,200 shares in Infollion Research IPO.
| Hemant Surgical Industries IPO | Infollion Research IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,82,400 shares | 7,24,800 shares |
| Market Maker Reservation | 1,44,000 shares | 1,32,800 shares |
| QIB | 5,23,200 shares | 4,83,200 shares |
| NII | 3,93,600 shares | 4,04,800 shares |
| RII | 9,16,800 shares | 8,70,400 shares |
| Employee | ||
| Others | ||
| Total | 26,16,000 shares | 24,83,200 shares |
Hemant Surgical Industries IPO subscribed 150.59x in total, whereas Infollion Research IPO subscribed 279.24x.
| Hemant Surgical Industries IPO | Infollion Research IPO | |
|---|---|---|
| QIB (times) | 41.05x | 70.72x |
| NII (times) | 277.26x | 560.71x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 158.73x | 264.10x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 150.59x | 279.24x |
